Jaguar Health, Inc. (JAGX) has announced a 1-for-25 reverse stock split of its common stock, effective Tuesday, November 24, 2026. In connection with this corporate action, the company's CUSIP number will be updated to 47010C839.
Jaguar Health will execute a one-for-twenty-five reverse stock split effective November 24, 2026, with the CUSIP changing to 47010C839. While the split itself is value-neutral, a split this large signals the shares trade at a distressed level and can trigger selling pressure as investors anticipate continued weakness. Trading and liquidity may also be disrupted around the effective date.
- ▼ 1-for-25 reverse stock split effective Tuesday, November 24, 2026
- ▼ CUSIP number change to 47010C839 in conjunction with the split
- ▲ Reverse split is mechanically value-neutral and requires no change in valuation
- ▲ Market maker registration is open, which could support liquidity after the split